Oragenics changes name to Oni Biopharma

The company recently registered in the State of Florida to do business as ONI BioPharma. The company will refer to itself as Oni BioPharma from this point forward and expects to seek to obtain shareholder approval to amend its articles of incorporation in order to formally change its name from Oragenics to ONI BioPharma in connection with the next annual meeting of shareholders.

The company believes that the new name more accurately reflects the broad range of scientific platforms and products that the company has under development through the efforts of its scientific team, headed by Jeffrey Hillman, the company’s chief scientific officer.

Richard Welch, chairman of Oragenics, said: “Although we remain committed to oral health, the company is active in the development of novel antibiotics and diagnostics as well and the new ‘doing business name,’ Oni BioPharma, conveys a better sense of a company that is active in other areas, in particular the infectious diseases arena.”